EMEA-000012-PIP01-07-M01

Key facts

Invented name
Singulair
Active substance
Montelukast sodium
Therapeutic area
Pneumology-allergology
Decision number
P/200/2009
PIP number
EMEA-000012-PIP01-07-M01
Pharmaceutical form(s)
  • Chewable tablet
  • Oral granules
Condition(s) / indication(s)
Asthma
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme Ltd.

E-mail: pip.information@merck.com
Tel. +31 412663179
Fax +31 412662571

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000012-PIP01-07-M01
Compliance opinion date
15/01/2010
Compliance outcome
positive

Decision

Topics

How useful was this page?

Add your rating
Average
1 rating